Maplight Therapeutics, Inc. · NASDAQ:MPLT

Kroeger Christopher A. sold 118,235 Maplight Therapeutics, Inc. shares (Form 4)

Traded May 18, 2026 · Filed May 18, 2026

On May 18, 2026, Kroeger Christopher A. (Director, Chief Executive Officer) sold 118,235 Maplight Therapeutics, Inc. shares at an average US$27.19 for US$3.21M under a trading plan, leaving 1,394,094 shares. Filed May 18, 2026 (Form 4).

Sold
118,235 shares
Price
US$27.19 average (US$27.19 to US$28.15)
Value
US$3.21M
Holding after
1,394,094 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 18, 2026Voting Common StockSale118,037US$27.191,394,292Direct
May 18, 2026Voting Common StockSale198US$28.151,394,094Direct

Source

View original at SEC

Related